Correction to article on Mylan earnings
09 Août 2017 - 7:33PM
Dow Jones News
The Food and Drug Administration earlier this year asked for
more information on Mylan drugs in development. "Mylan Defers
Product Launches," at 9:42 ET, incorrectly gave the name of the
agency as the Federal Drug Administration in the fourth paragraph.
(Aug. 9)
(END) Dow Jones Newswires
August 09, 2017 13:18 ET (17:18 GMT)
Copyright (c) 2017 Dow Jones & Company, Inc.
Teva Pharmaceutical Indu... (NYSE:TEVA)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024
Teva Pharmaceutical Indu... (NYSE:TEVA)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024